MichaelJosephMinaMDPhD

Pathology • Boston, MA

Anatomic Pathology, Clinical Pathology

Clinical Pathology

Join to view full profile

Dr. Mina is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mina's full profile

Already have an account?

Office
75 Francis St
Dept. Of Pathology
Boston, MA 02115
Phone+1 617-732-8613

Education & Training

Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2016 - 2020
Emory University School of MedicineClass of 2016
Princeton UniversityPost-Doctoral Fellowship, 2014 - 2015
Emory UniversityPh.D, Infectious Disease Immunology & Mathematics, 2007 - 2014
Dartmouth CollegeA.B., Senior Fellowship, 2002 - 2006

Certifications & Licensure

MA State Medical License 2016 - 2021

Publications & Presentations

PubMed

27 citations
Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK
Kartini Gadroen, Caitlin Dodd, Gwen M C Masclee, Maria A. J. de Ridder, Daniel Weibel
BMJ Open. 2018-11-01
37 citations
Antibody testing will enhance the power and accuracy of COVID-19-prevention trials.
Marc Lipsitch, Rebecca Kahn, Michael J. Mina
Nature Medicine. 2020-04-27
892 citations
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.
Kjetil Bjornevik, Marianna Cortese, Brian C Healy, Jens Kuhle, Michael J Mina
Science. 2022-01-21

Journal Articles

Test Sensitivity Is Secondary to Frequency and Turnaround Time for COVID-19 Surveillance
Michael Mina, MD, medRxiv

Authored Content

Test Sensitivity Is Secondary to Frequency and Turnaround Time for COVID-19 SurveillanceJune 2020
Test Sensitivity Is Secondary to Frequency and Turnaround Time for COVID-19 SurveillanceJune 2020

Press Mentions

40 Facts You NEED to Know: The REAL Story of “Covid” / by Kit KnightlyMarch 26th, 2023
“COVID Rebound” Is Common – Even in Patients Not Treated with PaxlovidMarch 13th, 2023
Understanding the Impact of Natural Immunity to COVID-19 on U.S. Health and PoliticsMarch 8th, 2023
Join now to see all